Loading stock data…
Sunshine Biopharma (SBFM)
$2.11-0.07 (-3.21%)
After Hours$2.11+0.00 (+0.00%)· Last close Jun 29
Sunshine Biopharma, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sunshine Biopharma, Inc. in the Healthcare sector is trading at $2.11 with a market capitalization of $5M. Wall Street consensus targets $56.00 (1 analysts), implying a +2554.0% move over the next 12 months. The stock is currently near its 52-week low of $2.00, remaining 81.9% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +2554.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.09M↓ | $8.58M↓ | $9.42M | $9.41M↑ | $8.90M |
| Gross Profit | $2.18M↓ | $3.03M↓ | $3.07M↓ | $3.42M↑ | $2.73M |
| Operating Income | -$1.40M↑ | -$1.66M↓ | -$531,963↑ | -$992,846↑ | -$1.30M |
| Net Income | -$1.24M↑ | -$2.14M↓ | -$883,820↑ | -$1.77M↓ | -$1.18M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is develo...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.67M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-28.07%
Volume
Today's trading volume
83,066
